Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 20392556)

Published in Eur J Obstet Gynecol Reprod Biol on April 13, 2010

Authors

Yoo-Young Lee1, Tae-Joong Kim, Chul-Jung Kim, Hwang Shin Park, Chel Hun Choi, Jeong-Won Lee, Je-ho Lee, Duk-Soo Bae, Byoung-Gie Kim

Author Affiliations

1: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea.

Articles citing this

Single-port access laparoscopic staging operation for a borderline ovarian tumor. J Gynecol Oncol (2011) 0.97

Laparoendoscopic single-site surgery in gynecology: LESS is actually how much less? J Midlife Health (2013) 0.97

Choosing the cosmetically superior laparoscopic access to the abdomen: the importance of the umbilicus. Surg Endosc (2011) 0.88

A comparison of clinical and surgical outcomes between laparo-endoscopic single-site surgery and traditional multiport laparoscopic surgery for adnexal tumors. Obstet Gynecol Sci (2014) 0.87

Single-port-access, hand-assisted laparoscopic surgery for benign large adnexal tumors versus single-port pure laparoscopic surgery for adnexal tumors. Surg Endosc (2011) 0.84

Asian society of gynecologic oncology workshop 2010. J Gynecol Oncol (2010) 0.81

Estimating causal effects in observational studies using Electronic Health Data: Challenges and (some) solutions. EGEMS (Wash DC) (2013) 0.80

Laparoendoscopic single-site surgery (LESS) versus conventional laparoscopic surgery for adnexal preservation: a randomized controlled study. Int J Womens Health (2012) 0.78

Adnexal Masses Treated Using a Combination of the SILS Port and Noncurved Straight Laparoscopic Instruments: Turkish Experience and Review of the Literature. Minim Invasive Surg (2013) 0.78

Single-port versus conventional multiport access prophylactic laparoscopic bilateral salpingo-oophorectomy in high-risk patients for ovarian cancer: a comparison of surgical outcomes. Onco Targets Ther (2015) 0.78

Early postoperative pain after keyless abdominal rope-lifting surgery. JSLS (2015) 0.78

Laparoendoscopic single-site versus conventional laparoscopic surgery for ovarian mature cystic teratoma. Obstet Gynecol Sci (2015) 0.77

Clinical experience with single-port access laparoscopic cystectomy and myomectomy. Clin Exp Reprod Med (2016) 0.75

Single Port Transumbilical Laparoscopic Surgery versus Conventional Laparoscopic Surgery for Benign Adnexal Masses: A Retrospective Study of Feasibility and Safety. Chin Med J (Engl) (2016) 0.75

Single-Incision Single-Instrument Adnexal Surgery in Pediatric Patients. Minim Invasive Surg (2015) 0.75

Single port access laparoscopic surgery for large adnexal tumors: Initial 51 cases of a single institute. Obstet Gynecol Sci (2017) 0.75

Port site infiltration of local anesthetic after laparoendoscopic single site surgery for benign adnexal disease. Obstet Gynecol Sci (2017) 0.75

Laparoendoscopic single-site adnexal surgery: Preliminary Indian experience. J Minim Access Surg (2017) 0.75

Articles by these authors

Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer. J Clin Oncol (2012) 3.49

Regulation of tumor angiogenesis by EZH2. Cancer Cell (2010) 3.10

Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res (2008) 2.42

Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clin Cancer Res (2009) 1.61

Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem (2010) 1.58

Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol (2012) 1.49

Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes. Surg Endosc (2010) 1.46

Clinical characteristics of adnexal masses in Korean children and adolescents: retrospective analysis of 409 cases. J Minim Invasive Gynecol (2010) 1.45

Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia (2011) 1.42

Single port access laparoscopic adnexal surgery. J Minim Invasive Gynecol (2009) 1.40

Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res (2012) 1.36

Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer (2007) 1.33

Single-port access laparoscopic-assisted vaginal hysterectomy: a novel method with a wound retractor and a glove. J Minim Invasive Gynecol (2009) 1.32

Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biol Ther (2009) 1.30

Benign metastasizing leiomyoma with multiple lymph node metastasis: a case report. Cancer Res Treat (2011) 1.29

Adenoid cystic carcinoma of the Bartholin's gland: report of two cases and review of the literature. Gynecol Oncol (2005) 1.25

Embryonic natural orifice transumbilical endoscopic surgery (E-NOTES) for adnexal tumors. Surg Endosc (2009) 1.22

Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol (2011) 1.22

The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol (2010) 1.20

Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett (2007) 1.15

Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol (2011) 1.15

Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol (2011) 1.13

Ecology of H3 avian influenza viruses in Korea and assessment of their pathogenic potentials. J Gen Virol (2008) 1.13

Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol (2005) 1.10

Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer. J Mol Cell Biol (2012) 1.10

AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med (2011) 1.08

Functional roles of Src and Fgr in ovarian carcinoma. Clin Cancer Res (2011) 1.08

Determination of substrate specificity and putative substrates of Chk2 kinase. Biochem Biophys Res Commun (2003) 1.07

Single-port access subtotal hysterectomy with transcervical morcellation: a pilot study. J Minim Invasive Gynecol (2009) 1.07

The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol (2009) 1.06

Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol (2010) 1.04

Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma. Gynecol Oncol (2007) 1.03

The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Gynecol Oncol (2009) 1.03

Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02

Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog (2007) 1.02

Metastatic skin lesions on lower extremities in a patient with recurrent serous papillary ovarian carcinoma: a case report and literature review. Cancer Res Treat (2012) 1.00